Allan Mulligan and Mr
Robert Mosig, as Proposed Non-Executive Technical Director and Proposed Non-Executive Director respectively, and Mr Shane Hibbird as Consulting Geologist. The Company also advises that it has requested cancellation of the admission to trading of its ordinary shares on AIM in order to facilitate implementation of its proposed acquisition of Great Northern Palladium Pty Ltd ( GNP ) which owns 80%, and holds an option over the remaining 20%, of Panton Sill Pty Ltd, the holder of the Panton Platinum Group Metals ( PGM ) Project (the Panton PGM Project ) in the Kimberley region of
Western Australia (the Proposed Acquisition ).
On completion of the Proposed Acquisition, further details of which were announced on
Red Emperor (ASX/AIM: RMP) is pleased to announce the proposed appointments of Mr Allan Mulligan and Mr Robert Mosig, as Proposed Non-Executive Technical Director and Proposed Non-Executive Director respectively, and Mr Shane Hibbird as Consulting Geologist. The Company also advises that it has requested cancellation of the admission to trading of its ordinary shares on AIM in order to facilitate implementation of its proposed acquisition of Great Northern Palladium Pty Ltd ( GNP ) which owns 80%, and holds an option over the remaining 20%, of Panton Sill Pty Ltd, the holder of the Panton Platinum Group Metals ( PGM ) Project (the Panton PGM Project ) in the Kimberley region of Western Australia (the Proposed Acquisition ).
EXECUTIVE CHANGES: James Fisher names new CFO; Lekoil loses new chair
Tue, 20th Apr 2021 15:36
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:
James Fisher & Sons PLC - Barrow In Furness, Cumbria-based marine services - Hires Duncan Kennedy as chief financial officer and executive director, starting May 4. Kennedy replaces Stuart Kilpatrick, who as previously announced will step down at the April 29 annual general meeting. Kennedy joins from BTG PLC, where he was CFO until the former FTSE 250 healthcare firm was acquired by Boston Scientific Corp in 2019.